Allianz Asset Management »

Dyne Therapeutics shares owned by Allianz Asset Management

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Allianz Asset Management from 13F filings

Historical chart of Allianz Asset Management investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Allianz Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Allianz Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $558k 16k 35.29

More positions owned by Allianz Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
UnitedHealth (UNH)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. Call Option (JPM)
Adobe Systems Incorporated (ADBE)
Vici Pptys (VICI)
Applied Materials (AMAT)
Ishares Tr Msci Emg Mkt Etf (EEM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Eli Lilly & Co. (LLY)

View all positions for Allianz Asset Management

Top funds holding Dyne Therapeutics

Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
BlackRock
BlackRock
RA Capital Management
Vanguard Group
Henderson Group
Deep Track Capital
State Street Corporation
Citadel Advisors
TCG Crossover Management
T. Rowe Price Associates
VR Adviser
Goldman Sachs Group
Holocene Advisors

View all funds holding Dyne Therapeutics